ENTERO Stock Overview
Engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, healthcare product manufacturers, and healthcare clinics in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ENTERO from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Entero Healthcare Solutions Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,423.40 |
| 52 Week High | ₹1,584.25 |
| 52 Week Low | ₹970.00 |
| Beta | 0 |
| 1 Month Change | 6.39% |
| 3 Month Change | 4.16% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 23.82% |
Recent News & Updates
Shareholder Returns
| ENTERO | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -2.8% | -0.2% | -2.1% |
| 1Y | n/a | 44.5% | 22.5% |
Return vs Industry: Insufficient data to determine how ENTERO performed against the Indian Healthcare industry.
Return vs Market: Insufficient data to determine how ENTERO performed against the Indian Market.
Price Volatility
| ENTERO volatility | |
|---|---|
| ENTERO Average Weekly Movement | 5.8% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: ENTERO has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ENTERO's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 3,240 | Prabhat Agrawal | www.enterohealthcare.com |
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, healthcare product manufacturers, and healthcare clinics in India. The company is involved in the distribution of medical devices, over the counter medical products, nutraceuticals, and vaccines. It also offers nebulizers, digital thermometers, blood pressure monitors, and adult diapers.
Entero Healthcare Solutions Limited Fundamentals Summary
| ENTERO fundamental statistics | |
|---|---|
| Market cap | ₹61.91b |
| Earnings (TTM) | ₹714.39m |
| Revenue (TTM) | ₹44.25b |
86.7x
P/E Ratio1.4x
P/S RatioIs ENTERO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ENTERO income statement (TTM) | |
|---|---|
| Revenue | ₹44.25b |
| Cost of Revenue | ₹40.24b |
| Gross Profit | ₹4.01b |
| Other Expenses | ₹3.29b |
| Earnings | ₹714.39m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 16.43 |
| Gross Margin | 9.06% |
| Net Profit Margin | 1.61% |
| Debt/Equity Ratio | 15.8% |
How did ENTERO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 23:01 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Entero Healthcare Solutions Limited is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nitin Agarwal | DAM Capital Advisors |
| Anshuman Gupta | Investec Bank plc (UK) |
| Alok Dalal | Jefferies LLC |